Literature DB >> 24228201

Hepatic fatty acid trafficking: multiple forks in the road.

Douglas G Mashek1.   

Abstract

The liver plays a unique, central role in regulating lipid metabolism. In addition to influencing hepatic function and disease, changes in specific pathways of fatty acid (FA) metabolism have wide-ranging effects on the metabolism of other nutrients, extra-hepatic physiology, and the development of metabolic diseases. The high prevalence of nonalcoholic fatty liver disease (NAFLD) has led to increased efforts to characterize the underlying biology of hepatic energy metabolism and FA trafficking that leads to disease development. Recent advances have uncovered novel roles of metabolic pathways and specific enzymes in generating lipids important for cellular processes such as signal transduction and transcriptional activation. These studies have also advanced our understanding of key branch points involving FA partitioning between metabolic pathways and have identified new roles for lipid droplets in these events. This review covers recent advances in our understanding of FA trafficking and its regulation. An emphasis will be placed on branch points in these pathways and how alterations in FA trafficking contribute to NAFLD and related comorbidities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24228201      PMCID: PMC3823518          DOI: 10.3945/an.113.004648

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  225 in total

1.  Temporal pattern of de novo lipogenesis in the postprandial state in healthy men.

Authors:  Maureen T Timlin; Elizabeth J Parks
Journal:  Am J Clin Nutr       Date:  2005-01       Impact factor: 7.045

Review 2.  Hepatic triacylglycerol accumulation and insulin resistance.

Authors:  Cynthia A Nagle; Eric L Klett; Rosalind A Coleman
Journal:  J Lipid Res       Date:  2008-11-06       Impact factor: 5.922

3.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity.

Authors:  Laura L Listenberger; Xianlin Han; Sarah E Lewis; Sylvaine Cases; Robert V Farese; Daniel S Ory; Jean E Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

4.  Lipogenesis in the pigeon: in vivo studies.

Authors:  A G Goodridge; E G Ball
Journal:  Am J Physiol       Date:  1967-07

Review 5.  The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.

Authors:  Kyoko Nomura; Toshikazu Yamanouchi
Journal:  J Nutr Biochem       Date:  2011-11-29       Impact factor: 6.048

6.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

7.  SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; Lan Hua; Kristin E Dittenhafer-Reed; Bjoern Schwer; David B Lombard; Yu Li; Jakob Bunkenborg; Frederick W Alt; John M Denu; Matthew P Jacobson; Eric Verdin
Journal:  Cell Metab       Date:  2010-12-01       Impact factor: 27.287

8.  A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.

Authors:  Maja Stefanovic-Racic; German Perdomo; Benjamin S Mantell; Ian J Sipula; Nicholas F Brown; Robert M O'Doherty
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-03-18       Impact factor: 4.310

9.  Identification of a physiologically relevant endogenous ligand for PPARalpha in liver.

Authors:  Manu V Chakravarthy; Irfan J Lodhi; Li Yin; Raghu R V Malapaka; H Eric Xu; John Turk; Clay F Semenkovich
Journal:  Cell       Date:  2009-07-30       Impact factor: 41.582

Review 10.  Peroxisome proliferator-activated receptor alpha target genes.

Authors:  S Mandard; M Müller; S Kersten
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

View more
  38 in total

1.  Kidney triglyceride accumulation in the fasted mouse is dependent upon serum free fatty acids.

Authors:  Diego Scerbo; Ni-Huiping Son; Alaa Sirwi; Lixia Zeng; Kelli M Sas; Vincenza Cifarelli; Gabriele Schoiswohl; Lesley-Ann Huggins; Namrata Gumaste; Yunying Hu; Subramaniam Pennathur; Nada A Abumrad; Erin E Kershaw; M Mahmood Hussain; Katalin Susztak; Ira J Goldberg
Journal:  J Lipid Res       Date:  2017-04-12       Impact factor: 5.922

2.  Oxidized tea polyphenols prevent lipid accumulation in liver and visceral white adipose tissue in rats.

Authors:  Sumin Wang; Yewei Huang; Huanhuan Xu; Qiangqiang Zhu; Hao Lu; Mengmeng Zhang; Shumei Hao; Chongye Fang; Dongying Zhang; Xiaoyun Wu; Xuanjun Wang; Jun Sheng
Journal:  Eur J Nutr       Date:  2016-06-07       Impact factor: 5.614

3.  FABP-1 gene ablation impacts brain endocannabinoid system in male mice.

Authors:  Gregory G Martin; Sarah Chung; Danilo Landrock; Kerstin K Landrock; Huan Huang; Lawrence J Dangott; Xiaoxue Peng; Martin Kaczocha; Drew R Seeger; Eric J Murphy; Mikhail Y Golovko; Ann B Kier; Friedhelm Schroeder
Journal:  J Neurochem       Date:  2016-06-22       Impact factor: 5.372

4.  Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.

Authors:  Abigail Wolf Greenstein; Neena Majumdar; Peng Yang; Papasani V Subbaiah; Rhonda D Kineman; Jose Cordoba-Chacon
Journal:  J Endocrinol       Date:  2016-10-31       Impact factor: 4.286

5.  FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein.

Authors:  Huan Huang; Avery L McIntosh; Gregory G Martin; Danilo Landrock; Sarah Chung; Kerstin K Landrock; Lawrence J Dangott; Shengrong Li; Ann B Kier; Friedhelm Schroeder
Journal:  Biochemistry       Date:  2016-09-02       Impact factor: 3.162

6.  Fabp1 gene ablation inhibits high-fat diet-induced increase in brain endocannabinoids.

Authors:  Gregory G Martin; Danilo Landrock; Sarah Chung; Lawrence J Dangott; Drew R Seeger; Eric J Murphy; Mikhail Y Golovko; Ann B Kier; Friedhelm Schroeder
Journal:  J Neurochem       Date:  2016-11-29       Impact factor: 5.372

7.  Loss of Hepatic Mitochondrial Long-Chain Fatty Acid Oxidation Confers Resistance to Diet-Induced Obesity and Glucose Intolerance.

Authors:  Jieun Lee; Joseph Choi; Ebru S Selen Alpergin; Liang Zhao; Thomas Hartung; Susanna Scafidi; Ryan C Riddle; Michael J Wolfgang
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

8.  Maternal cinnamon intake during lactation led to visceral obesity and hepatic metabolic dysfunction in the adult male offspring.

Authors:  Jessika Geisebel Oliveira Neto; Thais Bento-Bernardes; Carmen Cabanelas Pazos-Moura; Karen Jesus Oliveira
Journal:  Endocrine       Date:  2018-10-01       Impact factor: 3.633

9.  High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine.

Authors:  M R Panasevich; G M Meers; M A Linden; F W Booth; J W Perfield; K L Fritsche; Umesh D Wankhade; Sree V Chintapalli; K Shankar; J A Ibdah; R S Rector
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-09-12       Impact factor: 4.310

Review 10.  Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.

Authors:  Friedhelm Schroeder; Avery L McIntosh; Gregory G Martin; Huan Huang; Danilo Landrock; Sarah Chung; Kerstin K Landrock; Lawrence J Dangott; Shengrong Li; Martin Kaczocha; Eric J Murphy; Barbara P Atshaves; Ann B Kier
Journal:  Lipids       Date:  2016-04-27       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.